ALNY Alnylam Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc (ALNY) Hedge Fund Activity
This view isolates hedge funds from the broader institutional ownership shown on the Institutional tab. A pension fund tracking an index may have no view on a stock; when a hedge fund builds or exits a position, that decision can carry information. This page measures those changes. Positions as of June 30, 2026.
Based on quarterly 13F long-equity filings. Changes compare reported quarter-end positions; filings can be reported up to 45 days later and do not represent a fund's complete exposure.
Most significant moves
Ranked by conviction, not size — how much of the fund's own book the position represents, how far it moved, and what kind of fund made it.
| Fund | Action | Shares changed | Change | Est. value | Portfolio wt. | Score |
|---|---|---|---|---|---|---|
| Deep Track Capital Growth Healthcare | New | +825.0K | — | $248.3M | 3.7% | 86 |
| Paradigm BioCapital Advisors Growth Healthcare | New | +480.0K | — | $144.5M | 2.7% | 81 |
| Balyasny Asset Management L.P. | New | +89.5K | — | $26.9M | 0.1% | 61 |
| CITADEL ADVISORS LLC Quant | Increased | +167.6K | +715.8% | $50.5M | 0.0% | 58 |
| Soleus Capital Management Growth Healthcare | Reduced | -98.6K | -74.9% | $29.7M | 0.3% | 57 |
| MARSHALL WACE, LLP Long/Short | Reduced | -839.5K | -76.4% | $252.7M | 0.1% | 57 |
| J. Goldman & Co. Long/Short | New | +38.7K | — | $11.6M | 0.5% | 56 |
| OrbiMed Advisors Growth Healthcare | Reduced | -102.0K | -85.7% | $30.7M | 0.1% | 56 |
| Voloridge Investment Management Quant | Reduced | -184.7K | -97.6% | $55.6M | 0.0% | 54 |
| Verition Fund Management Event Long/Short | Sold Out | -898 | -100.0% | $270.3K | 0.0% | 54 |
Most significant buyers
By move score, not size.
- Deep Track Capital
- Paradigm BioCapital Advisors
- Balyasny Asset Management L.P.
- CITADEL ADVISORS LLC
- J. Goldman & Co.
Most significant sellers
By move score, not size.
- Soleus Capital Management
- MARSHALL WACE, LLP
- OrbiMed Advisors
- Voloridge Investment Management
- Verition Fund Management
Hedge fund positions
| Fund | Tier | Shares | Previous | Change | Change % | Portfolio wt. | Action | Score |
|---|---|---|---|---|---|---|---|---|
| Deep Track Capital | 1 | 825.0K | 0 | +825.0K | — | 3.7% | New | 86 |
| Paradigm BioCapital Advisors | 1 | 480.0K | 0 | +480.0K | — | 2.7% | New | 81 |
| Balyasny Asset Management L.P. | 2 | 89.5K | 0 | +89.5K | — | 0.1% | New | 61 |
| CITADEL ADVISORS LLC | 1 | 191.0K | 23.4K | +167.6K | +715.8% | 0.0% | Increased | 58 |
| Soleus Capital Management | 2 | 33.1K | 131.7K | -98.6K | -74.9% | 0.3% | Reduced | 57 |
| MARSHALL WACE, LLP | 2 | 259.8K | 1.1M | -839.5K | -76.4% | 0.1% | Reduced | 57 |
| J. Goldman & Co. | 3 | 38.7K | 0 | +38.7K | — | 0.5% | New | 56 |
| OrbiMed Advisors | 2 | 17.0K | 119.0K | -102.0K | -85.7% | 0.1% | Reduced | 56 |
| Voloridge Investment Management | 2 | 4.5K | 189.2K | -184.7K | -97.6% | 0.0% | Reduced | 54 |
| Verition Fund Management | 2 | 0 | 898 | -898 | -100.0% | 0.0% | Sold Out | 54 |
| Caxton Associates | 3 | 952 | 0 | +952 | — | 0.0% | New | 53 |
| Hudson Bay Capital Management | 3 | 148.7K | 40.0K | +108.7K | +271.8% | 0.3% | Increased | 53 |
| CenterBook Partners | 4 | 12.2K | 0 | +12.2K | — | 0.2% | New | 51 |
| Edgestream Partners | 4 | 0 | 5.8K | -5.8K | -100.0% | 0.0% | Sold Out | 51 |
| Boothbay Fund Management | 4 | 6.2K | 0 | +6.2K | — | 0.0% | New | 51 |
| Winton Group | 4 | 7.9K | 0 | +7.9K | — | 0.1% | New | 51 |
| Cinctive Capital Management | 3 | 3.3K | 0 | +3.3K | — | 0.0% | New | 50 |
| Graham Capital Management | 3 | 2.3K | 0 | +2.3K | — | 0.0% | New | 49 |
| LMR Partners | 3 | 134.2K | 74.7K | +59.6K | +79.8% | 0.5% | Increased | 48 |
| Capstone Investment Advisors | 3 | 1.9K | 753 | +1.1K | +152.2% | 0.0% | Increased | 47 |
| Quadrature Capital | 3 | 22.7K | 85.2K | -62.6K | -73.4% | 0.1% | Reduced | 46 |
| Quantbot Technologies | 4 | 0 | 45 | -45 | -100.0% | 0.0% | Sold Out | 45 |
| Squarepoint Ops LLC | 2 | 234.0K | 426.7K | -192.7K | -45.2% | 0.2% | Reduced | 43 |
| Voleon Capital Management | 3 | 5.2K | 24.1K | -18.9K | -78.4% | 0.0% | Reduced | 42 |
| Brevan Howard Capital Management | 3 | 1.1K | 4.6K | -3.5K | -75.7% | 0.0% | Reduced | 39 |
| Schonfeld Strategic Advisors | 3 | 31.1K | 71.8K | -40.7K | -56.6% | 0.1% | Reduced | 39 |
| WORLDQUANT MILLENNIUM ADVISORS LLC | 2 | 62.2K | 42.2K | +20.0K | +47.5% | 0.1% | Increased | 39 |
| MILLENNIUM MANAGEMENT LLC | 2 | 316.0K | 447.9K | -131.9K | -29.4% | 0.1% | Reduced | 38 |
| Bridgewater Associates | 1 | 99.6K | 106.6K | -7.0K | -6.6% | 0.1% | Reduced | 35 |
| TWO SIGMA INVESTMENTS, LP | 2 | 1.9M | 2.0M | -116.6K | -5.9% | 0.5% | Reduced | 34 |
| Rock Springs Capital Management | 3 | 66.8K | 74.0K | -7.3K | -9.8% | 1.0% | Reduced | 34 |
| D. E. Shaw & Co., Inc. | 1 | 1.1M | 1.1M | +45.0K | +4.3% | 0.2% | Increased | 33 |
| Aquatic Capital Management | 4 | 15.5K | 31.1K | -15.6K | -50.2% | 0.2% | Reduced | 33 |
| Man Group | 3 | 170.9K | 232.4K | -61.5K | -26.5% | 0.1% | Reduced | 32 |
| AQR Capital Management | 3 | 728.0K | 913.1K | -185.1K | -20.3% | 0.1% | Reduced | 31 |
| Qube Research & Technologies Ltd | 2 | 798.7K | 838.2K | -39.5K | -4.7% | 0.3% | Reduced | 31 |
| Tremblant Capital Group | 2 | 92.9K | 94.6K | -1.6K | -1.7% | 0.8% | Reduced | 30 |
| Y-Intercept | 4 | 6.6K | 11.4K | -4.8K | -42.2% | 0.0% | Reduced | 30 |
| Capital Fund Management | 3 | 155.9K | 140.1K | +15.8K | +11.3% | 0.3% | Increased | 29 |
| Jain Global | 3 | 55.7K | 48.0K | +7.7K | +16.1% | 0.2% | Increased | 28 |
| Trexquant Investment | 3 | 48.2K | 61.8K | -13.6K | -22.0% | 0.1% | Reduced | 28 |
| Capula Management | 2 | 13.2K | 13.1K | +88 | +0.7% | 0.1% | Increased | 25 |
| Walleye Capital | 3 | 3.2K | 2.6K | +516 | +19.6% | 0.0% | Increased | 25 |
| Woodline Partners LP | 2 | 246.3K | 243.9K | +2.4K | +1.0% | 0.2% | Increased | 25 |
| Gotham Asset Management, LLC | 2 | 42.1K | 43.7K | -1.7K | -3.8% | 0.0% | Reduced | 25 |
| Engineers Gate | 4 | 33.5K | 32.5K | +967 | +3.0% | 0.1% | Increased | 18 |
| Deerfield Management | 1 | 67.9K | 67.9K | 0 | +0.0% | 0.3% | Unchanged | 26 |
Every fund above opens. Subscribers can see any manager's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeHedge funds are identified from their 13F filings, which are due 45 days after quarter end and cover long U.S.-listed equity positions only. A fund's short book never appears, so a reduced position can mean a changed view or a changed hedge — the filing doesn't say which.